相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Kinase-Inactivated EGFR Is Required for the Survival of Wild-Type EGFR-Expressing Cancer Cells Treated with Tyrosine Kinase Inhibitors
Rintu Thomas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion
Hong-Jen Lee et al.
NATURE COMMUNICATIONS (2019)
Wild-type and mutated IDH1/2 enzymes and therapy responses
Remco J. Molenaar et al.
ONCOGENE (2018)
Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer
Jiangjiang Li et al.
THERANOSTICS (2018)
Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer
Pei-Chih Lee et al.
CANCER CELL (2018)
Oxygen availability and metabolic reprogramming in cancer
Hong Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis
Min Yu et al.
ONCOTARGET (2017)
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
Kimberly J. Briggs et al.
CELL (2016)
The DNA Damage Transducer RNF8 Facilitates Cancer Chemoresistance and Progression through Twist Activation
Hong-Jen Lee et al.
MOLECULAR CELL (2016)
K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression
Han-Tsang Wu et al.
NATURE COMMUNICATIONS (2016)
Fundamentals of cancer metabolism
Ralph J. DeBerardinis et al.
SCIENCE ADVANCES (2016)
Oxygen availability and metabolic adaptations
Michael S. Nakazawa et al.
NATURE REVIEWS CANCER (2016)
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Nissim Hay
NATURE REVIEWS CANCER (2016)
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer
Fanny Dupuy et al.
CELL METABOLISM (2015)
Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6
Eunyoung Park et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP
Liangliang Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma
Tapan K. Maity et al.
CANCER DISCOVERY (2015)
Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6
Eunyoung Park et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Mutations in EGFR, BRAF and RAS are rare in triple-negative and basal-like breast cancers from Caucasian women
E. Tilch et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
The TGFβ-miR200-MIG6 Pathway Orchestrates the EMT-Associated Kinase Switch That Induces Resistance to EGFR Inhibitors
Evgeny Izumchenko et al.
CANCER RESEARCH (2014)
Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential
Helene Pelicano et al.
BREAST CANCER RESEARCH (2014)
A Genome-wide siRNA Screen Identifies Proteasome Addiction as a Vulnerability of Basal-like Triple-Negative Breast Cancer Cells
Fabio Petrocca et al.
CANCER CELL (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers
Libero Santarpia et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis
Chia-Hsin Chan et al.
CELL (2012)
Search for a Gene Expression Signature of Breast Cancer Local Recurrence in Young Women
Nicolas Servant et al.
CLINICAL CANCER RESEARCH (2012)
Mig6 Is a Sensor of EGF Receptor Inactivation that Directly Activates c-Abl to Induce Apoptosis during Epithelial Homeostasis
Sarah Hopkins et al.
DEVELOPMENTAL CELL (2012)
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Christian M. Metallo et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
A gene expression signature identifies two prognostic subgroups of basal breast cancer
Renaud Sabatier et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers
Nicolaos Palaskas et al.
CANCER RESEARCH (2011)
The Evolving War on Cancer
Daniel A. Haber et al.
CELL (2011)
Modulation of Glucose Transporter 1 (GLUT1) Expression Levels Alters Mouse Mammary Tumor Cell Growth In Vitro and In Vivo
Christian D. Young et al.
PLOS ONE (2011)
Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability
David R. Wise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Glut-1 Expression Correlates with Basal-like Breast Cancer
Yaser R. Hussein et al.
TRANSLATIONAL ONCOLOGY (2011)
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
Amar J. Majmundar et al.
MOLECULAR CELL (2010)
Mig-6 controls EGFR trafficking and suppresses gliomagenesis
Haoqiang Ying et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity
S. Anastasi et al.
ONCOGENE (2007)
Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface
Xuewu Zhang et al.
NATURE (2007)
Evidence that MIG-6 is a tumor-suppressor gene
Y-W Zhang et al.
ONCOGENE (2007)
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
Bas Kreike et al.
BREAST CANCER RESEARCH (2007)
Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation
Ingvar Ferby et al.
NATURE MEDICINE (2006)
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
I Papandreou et al.
CELL METABOLISM (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin
S Anastasi et al.
ONCOGENE (2005)
Gene 33 inhibits apoptosis of breast cancer cells and increases poly(ADP-ribose) polymerase expression
J Xu et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma
SS Kang et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2002)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Regulation of glut1 mRNA by hypoxia-inducible factor-1 -: Interaction between H-ras and hypoxia
CH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Accelerated publication -: Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc
RC Osthus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
